We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+13.52%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.86B
AUM Growth
+$155M
Cap. Flow
-$4.62M
Cap. Flow %
-0.25%
Top 10 Hldgs %
25.53%
Holding
256
New
8
Increased
83
Reduced
147
Closed
9

Top Buys

Rank Stock Value
1
WIX icon
WIX.com
WIX
+$14.2M
2
GTLS
Chart Industries
GTLS
+$14.2M
3
ZD icon
Ziff Davis
ZD
+$7.41M
4
MTN icon
Vail Resorts
MTN
+$6.65M
5
WEX icon
WEX
WEX
+$6.06M

Top Sells

Rank Stock Value
1
LRN icon
Stride
LRN
+$19M
2
VRNA
Verona Pharma
VRNA
+$15.9M
3
RBA icon
RB Global
RBA
+$8.67M
4
TKO icon
TKO Group
TKO
+$7.05M
5
AGM icon
Federal Agricultural Mortgage
AGM
+$6.68M

Sector Composition

Rank Sector Weight
1 Healthcare 31.2%
2 Technology 28.31%
3 Industrials 17.54%
4 Communication Services 6.8%
5 Consumer Discretionary 6.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRKR icon
226
Bruker
BRKR
$8.52B
$427K 0.02%
10,361
+8
+0.1% +$309
SYY icon
227
Sysco
SYY
$40.4B
$414K 0.02%
5,464
ZBH icon
228
Zimmer Biomet
ZBH
$18.3B
$407K 0.02%
4,461
-382
-8% -$36.9K
GBCI icon
229
Glacier Bancorp
GBCI
$6.31B
$398K 0.02%
9,232
-75
-0.8% -$3.11K
DLB icon
230
Dolby
DLB
$5.8B
$396K 0.02%
5,337
+10
+0.2% +$749
MSFT icon
231
Microsoft
MSFT
$3.79T
$396K 0.02%
796
+37
+5% +$16.1K
WMT icon
232
Walmart Inc
WMT
$888B
$388K 0.02%
3,973
DENN
233
DELISTED
Denny's
DENN
$383K 0.02%
93,408
+5,120
+6% +$19.6K
KBR icon
234
KBR
KBR
$4.83B
$375K 0.02%
7,826
-50
-0.6% -$2.59K
MCO icon
235
Moody's
MCO
$83.2B
$347K 0.02%
691
+78
+13% +$36.1K
PG icon
236
Procter & Gamble
PG
$339B
$331K 0.02%
2,079
+280
+16% +$45.7K
ICLR icon
237
Icon
ICLR
$12.7B
$331K 0.02%
2,274
-80
-3% -$11.3K
BMRN icon
238
BioMarin Pharmaceuticals
BMRN
$12.6B
$317K 0.02%
5,768
-112
-2% -$6.59K
WDFC icon
239
WD-40
WDFC
$3.15B
$308K 0.02%
1,350
MRSH
240
Marsh
MRSH
$91.3B
$295K 0.02%
1,350
CXT icon
241
Crane NXT
CXT
$2.96B
$255K 0.01%
4,736
-5
-0.1% -$255
HAS icon
242
Hasbro
HAS
$13.2B
$253K 0.01%
3,421
-34
-1% -$2.14K
DVN icon
243
Devon Energy
DVN
$49.1B
$248K 0.01%
7,796
-34
-0.4% -$1.08K
COLM icon
244
Columbia Sportswear
COLM
$2.91B
$230K 0.01%
3,769
-27
-0.7% -$1.74K
RCKT icon
245
Rocket Pharmaceuticals
RCKT
$399M
$226K 0.01%
92,398
+4,879
+6% +$24.7K
SBUX icon
246
Starbucks
SBUX
$120B
$224K 0.01%
2,445
PLRX icon
247
Pliant Therapeutics
PLRX
$65M
$187K 0.01%
161,248
+8,254
+5% +$11.7K
AIN icon
248
Albany International
AIN
$1.75B
-50,406
Closed -$3.48M
BLBD icon
249
Blue Bird Corp
BLBD
$2.09B
-29,374
Closed -$951K
CLNE icon
250
Clean Energy Fuels
CLNE
$348M
-315,180
Closed -$489K

Similar funds

Rice Hall James & Associates's Q2 2025 Portfolio in Review

As of Q2 2025, Rice Hall James & Associates held 256 positions worth $1.86B, up 9.1% from $1.7B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Rice Hall James & Associates's Q2 2025 filing shows 8 new, 83 increased, 147 reduced and 9 closed positions. Its largest new stake was Latham Group: 582,123 shares worth $3.71M. The largest sale was Stride, an estimated $19M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Industrials.

  • Rice Hall James & Associates's largest Q2 2025 buy was Latham Group: 582,123 shares worth $3.71M.
  • Rice Hall James & Associates added most to WIX.com in Q2 2025, an estimated $14.2M increase.
  • Rice Hall James & Associates's biggest Q2 2025 reduction was Stride, cutting an estimated $19M.
  • Rice Hall James & Associates fully exited Albany International in Q2 2025, selling an estimated $3.48M.
  • Rice Hall James & Associates's ten largest holdings make up 26% of its $1.86B portfolio in Q2 2025.
  • Rice Hall James & Associates opened 8 new positions and closed 9 in Q2 2025.
  • Rice Hall James & Associates's portfolio value rose 9.1% quarter-over-quarter to $1.86B.

Based on Rice Hall James & Associates's 13F filing for Q2 2025, filed 11 Aug 2025.